Fig. 1.
Fig. 1. Plasma viral load in rhesus macaques following SIVmac239 infection. / (A) Virus-only control group (monkeys RM1a and RM1b). (B) SIV infection and a 28-day course of PMPA chemotherapy (monkeys RM2a, RM2b, RM2c). (C) SIV infection, PMPA chemotherapy, and infusion with autologous unfractionated PBMCs (monkeys RM3a, RM3b, RM3c). (D) SIV infection, PMPA chemotherapy, and infusion with anti-CD3/CD28-activated autologous CD4+ T cells (monkeys RM4a, RM4b, RM4c).

Plasma viral load in rhesus macaques following SIVmac239 infection.

(A) Virus-only control group (monkeys RM1a and RM1b). (B) SIV infection and a 28-day course of PMPA chemotherapy (monkeys RM2a, RM2b, RM2c). (C) SIV infection, PMPA chemotherapy, and infusion with autologous unfractionated PBMCs (monkeys RM3a, RM3b, RM3c). (D) SIV infection, PMPA chemotherapy, and infusion with anti-CD3/CD28-activated autologous CD4+ T cells (monkeys RM4a, RM4b, RM4c).

Close Modal

or Create an Account

Close Modal
Close Modal